Trials / Completed
CompletedNCT00163163
Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women
Carotid Atorvastatin Study In Hyperlipidemic Post-Menopausal Women: A Randomized Evaluation of Atorvastatin, Versus Placebo (CASHMERE)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 400 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect of atorvastatin 80 mg, versus placebo, given for 12 months on carotid intima-media thickness in postmenopausal women with moderate hypercholesterolemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Echographic measurements | |
| PROCEDURE | Blood samples |
Timeline
- Start date
- 2003-01-01
- Completion
- 2006-07-01
- First posted
- 2005-09-13
- Last updated
- 2021-02-18
Locations
69 sites across 3 countries: Belgium, France, Netherlands
Source: ClinicalTrials.gov record NCT00163163. Inclusion in this directory is not an endorsement.